Vitamin D Levels in Black Americans and the Association With Left Ventricular Remodeling and Incident Heart Failure

Daisuke Kamimura1, Wondwosen K Yimer2, Amil M Shah3

  • 1Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Insights

Lower vitamin D3 levels are linked to heart changes and increased risk of heart failure with preserved ejection fraction (HFpEF) in Black Americans. This highlights a potential role for vitamin D3 in cardiovascular health for this population.

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Science
  • Epidemiology

Background:

  • Lower serum vitamin D3 concentrations are linked to increased cardiovascular disease risk.
  • Vitamin D3 deficiency is more prevalent in Black Americans.
  • Associations between vitamin D3 levels and left ventricular (LV) structure/function, particularly HFpEF, are not well-established in Black Americans.

Purpose of the Study:

  • To investigate the association between serum vitamin D3 levels and LV structure and function.
  • To examine the relationship between serum vitamin D3 levels and incident heart failure (HF), specifically HFpEF, in Black Americans.

Main Methods:

  • Analysis of 5306 Black Americans from the Jackson Heart Study cohort.
  • Echocardiography used to assess LV structure and function.
  • Incident HF hospitalizations were categorized as HF with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF).
  • Statistical adjustments for potential confounding factors were performed.

Main Results:

  • Lower vitamin D3 levels were associated with greater LV relative wall thickness.
  • Higher serum vitamin D3 levels were associated with a decreased hazard for overall HF.
  • This protective association was primarily driven by a significant reduction in the hazard for HFpEF.

Conclusions:

  • Lower serum vitamin D3 levels are associated with LV concentric remodeling and increased risk of HF, particularly HFpEF, in Black Americans.
  • Further research is needed to determine if vitamin D3 supplementation can prevent LV remodeling and HFpEF in this population.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
39